Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Inflammatory Carcinoma”

134 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 134 results

Very early researchStudy completedNCT01894451
What this trial is testing

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Who this might be right for
Inflammatory Breast Carcinoma
Dana-Farber Cancer Institute 2
Early research (Phase 1)WithdrawnNCT05093387
What this trial is testing

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Breast Inflammatory CarcinomaMetastatic Triple-Negative Breast Carcinoma+1 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01325428
What this trial is testing

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Study completedNCT00111787
What this trial is testing

Study Of Lapatinib In Combination With Paclitaxel In The Treatment Of Newly Diagnosed Inflammatory Breast Cancer

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 49
Not applicableStudy completedNCT00033397
What this trial is testing

Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 360
Not applicableNot Yet RecruitingNCT06131632
What this trial is testing

Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Inflammatory Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT02411656
What this trial is testing

Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy

Who this might be right for
EdemaErythemaEstrogen Receptor Negative+6 more
M.D. Anderson Cancer Center 71
Testing effectiveness (Phase 2)Ended earlyNCT02389764
What this trial is testing

Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC)

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 10
Early research (Phase 1)UnknownNCT04660929
What this trial is testing

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

Who this might be right for
HER2-positiveAdenocarcinomaBile Duct Cancer+28 more
Carisma Therapeutics Inc 48
Large-scale testing (Phase 3)UnknownNCT00003679
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT03012100
What this trial is testing

Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer

Who this might be right for
Bilateral Breast CarcinomaBreast Inflammatory CarcinomaStage IB Breast Cancer AJCC v7+9 more
Academic and Community Cancer Research United 280
Early research (Phase 1)UnknownNCT06065592
What this trial is testing

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms

Who this might be right for
CancerSolid TumorThromboembolism+10 more
Lebanese University 500
Testing effectiveness (Phase 2)Ended earlyNCT02892734
What this trial is testing

Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer

Who this might be right for
HER2/Neu NegativeRecurrent Inflammatory Breast CarcinomaStage IV Breast Cancer+1 more
Northwestern University 3
Testing effectiveness (Phase 2)UnknownNCT00002627
What this trial is testing

Addition of Paclitaxel to High-Dose Combination Chemotherapy in Treating Patients With High-Risk Breast Cancer

Who this might be right for
Breast Cancer
St. Louis University 30
Early research (Phase 1)Study completedNCT00004074
What this trial is testing

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

Who this might be right for
Advanced Adult Primary Liver CancerAnaplastic Thyroid CancerBone Metastases+124 more
National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Ended earlyNCT00028704
What this trial is testing

Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 26
Testing effectiveness (Phase 2)Study completedNCT00182793
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT00499122
What this trial is testing

NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer

Who this might be right for
Breast Cancer
University of Miami 41
Early research (Phase 1)Study completedNCT02900664
What this trial is testing

PDR001 in Combination With CJM112, EGF816, Ilaris® (Canakinumab) or Mekinist® (Trametinib)

Who this might be right for
Colorectal Cancer, Triple Negative Breast Cancer, NSCLC - Adenocarcinoma
Novartis Pharmaceuticals 283
Not applicableUnknownNCT01038258
What this trial is testing

Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy

Who this might be right for
Invasive Ductal CarcinomaLobular Breast CarcinomaInflammatory Breast Carcinoma
Auxilio Mutuo Cancer Center 80
Load More Results